Mass. Drugmaker Sued After Antibiotic Fails, Shares Tank
Startup drugmaker Tetraphase Pharmaceuticals misled investors with rosy statements about an experimental antibiotic, causing them huge losses when a clinical trial failed and sent shares into a tailspin, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article